Nondipping in Parkinson's Disease

Overview

Journal Parkinsons Dis

Publisher Wiley

Date 2011 Sep 24

PMID 21941684

Citations 24

Authors

Sita Sommer

Billur Aral-Becher

Wolfgang Jost

Affiliations

Soon will be listed here.

Abstract

Objective. The aim of this study was to identify patients with Parkinson's disease who showed loss or decrease of nocturnal blood pressure fall (nondipper patients) as a marker of autonomic dysfunction. Presence or absence of orthostatic hypotension was considered to investigate whether alterations in circadian blood pressure pattern are associated with posture-related dysregulation of blood pressure. Methods. 40 patients with Parkinson's disease underwent 24-hour blood pressure monitoring. 21 patients were diagnosed with arterial hypertension and received anti-hypertensive drugs. Nondipper patients were defined as having nocturnal decrease of mean systolic and diastolic blood pressure less than 10%. Presence or absence of orthostatic hypotension was determined by Schellong's test. Results. We identified 35 nondipper patients (88%). Nondipping was detected in 20 patients with orthostatic hypotension (95%) and in 15 patients without orthostatic hypotension (79%). 18 patients with hypertensive and 22 patients with normal blood pressure values were detected. Conclusions. In conclusion 24-hour blood pressure monitoring showed a high prevalence of nondipping in 40 patients with Parkinson's disease with and without orthostatic hypotension independent of coexisting arterial hypertension and antihypertensive treatment. 24-hour blood pressure monitoring may be useful to identify non-dipping as a marker of autonomic dysfunction in patients with Parkinson's disease.

Citing Articles

Seasonality as a risk factor for deaths in Parkinson's disease.

Fonseca M, Sansone D, Farah D, Fiorini A, Scorza C, Scorza F Clinics (Sao Paulo). 2024; 79:100506.

PMID: 39461195 PMC: 11543644. DOI: 10.1016/j.clinsp.2024.100506.

Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians.

Ip C, Kassubek J, Storch A, Tonges L, Wolz M, Jost W J Neural Transm (Vienna). 2024; 131(10):1263-1273.

PMID: 39370478 DOI: 10.1007/s00702-024-02838-3.

Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).

Khalil I, Sayad R, Kedwany A, Sayed H, Caprara A, Rissardo J Med Int (Lond). 2024; 4(6):70.

PMID: 39355336 PMC: 11443310. DOI: 10.3892/mi.2024.194.

Neurogenic Supine Hypertension and Cardiovascular Autonomic Dysfunction in Patients with Parkinson's Disease.

Kapoor S, Saluja A, Margekar S, Agarwal M, Mondal S, Dhamija R Ann Indian Acad Neurol. 2023; 26(1):33-38.

PMID: 37034036 PMC: 10081556. DOI: 10.4103/aian.aian_476_22.

Parkinson's disease and cardiovascular involvement: Edifying insights (Review).

Grosu L, Grosu A, Crisan D, Zlibut A, Perju-Dumbrava L Biomed Rep. 2023; 18(3):25.

PMID: 36846617 PMC: 9944619. DOI: 10.3892/br.2023.1607.

References

Senard J, Chamontin B, RASCOL A, Montastruc J . Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res. 1992; 2(2):99-104. DOI: 10.1007/BF01819664. View

Cornelissen G, Halberg F, Otsuka K, Singh R, Chen C . Chronobiology predicts actual and proxy outcomes when dipping fails. Hypertension. 2006; 49(1):237-9. PMC: 2613012. DOI: 10.1161/01.HYP.0000250392.51418.64. View

Jost W, Del Tredici K, Landvogt C, Braune S . Importance of 123I-metaiodobenzylguanidine scintigraphy/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromes. Neurodegener Dis. 2010; 7(5):341-7. DOI: 10.1159/000314573. View

Ejaz A, Sekhon I, Munjal S . Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson's disease. Eur J Intern Med. 2006; 17(6):417-20. DOI: 10.1016/j.ejim.2006.02.020. View

Veerman D, Imholz B, Wieling W, Wesseling K, van Montfrans G . Circadian profile of systemic hemodynamics. Hypertension. 1995; 26(1):55-9. DOI: 10.1161/01.hyp.26.1.55. View

Horan M . Role of ambulatory blood pressure recording in the diagnosis, prognosis, and management of hypertension. Clin Exp Hypertens A. 1985; 7(2-3):205-16. DOI: 10.3109/10641968509073540. View

Walter B . Cardiovascular autonomic dysfunction in patients with movement disorders. Cleve Clin J Med. 2008; 75 Suppl 2:S54-8. DOI: 10.3949/ccjm.75.suppl_2.s54. View

Pickering T . Strategies for the evaluation and treatment of hypertension and some implications of blood pressure variability. Circulation. 1987; 76(1 Pt 2):I77-82. View

Langston J, FORNO L . The hypothalamus in Parkinson disease. Ann Neurol. 1978; 3(2):129-33. DOI: 10.1002/ana.410030207. View

10.

Haensch C, Jorg J . Beat-to-beat blood pressure analysis after premature ventricular contraction indicates sensitive baroreceptor dysfunction in Parkinson's disease. Mov Disord. 2005; 21(4):486-91. DOI: 10.1002/mds.20744. View

11.

. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996; 46(5):1470. DOI: 10.1212/wnl.46.5.1470. View

12.

Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C . Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson's disease and multiple system atrophy. J Hypertens. 1998; 16(10):1433-41. DOI: 10.1097/00004872-199816100-00006. View

13.

Moore D, West A, Dawson V, Dawson T . Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci. 2005; 28:57-87. DOI: 10.1146/annurev.neuro.28.061604.135718. View

14.

Biaggioni I, Robertson R, Robertson D . Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol. 1994; 34(5):418-23. DOI: 10.1002/j.1552-4604.1994.tb04981.x. View

15.

Rajput A, ROZDILSKY B . Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1976; 39(11):1092-100. PMC: 1083309. DOI: 10.1136/jnnp.39.11.1092. View

16.

Gross M, Bannister R . Orthostatic hypotension in Parkinson's disease. Lancet. 1972; 1(7743):174-6. DOI: 10.1016/s0140-6736(72)90571-5. View

17.

Friedrich C, Rudiger H, Schmidt C, Herting B, Prieur S, Junghanns S . Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transm (Vienna). 2008; 115(11):1527-36. DOI: 10.1007/s00702-008-0127-3. View

18.

Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K . Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004; 318(1):121-34. DOI: 10.1007/s00441-004-0956-9. View

19.

Pathak A, Senard J . Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management. Expert Rev Neurother. 2006; 6(8):1173-80. DOI: 10.1586/14737175.6.8.1173. View

20.

Schmidt C, Berg D, Prieur S, Junghanns S, Schweitzer K, Globas C . Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord. 2009; 24(14):2136-42. DOI: 10.1002/mds.22767. View